Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515872 · ClinicalTrials.gov registry record · Phase 2
Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis
A Phase 2 study, sponsored by ZetrOZ.
- Not yet
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
NCT07515872 is a Phase 2 study that has not yet begun recruiting, run by ZetrOZ. The registered enrollment target is 240 participants.
The verdict
NCT07515872, a Phase 2 study, has not yet begun recruiting, sponsored by ZetrOZ.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week period. The primary objective of this study is to evaluate the analgesic effect of ultrasound treatment in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of ultrasound treatment to improve joint function.
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DEVICE Sustained Acoustic Device with 0% Diclofenac Patch
- DRUG Intra articular injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07515872
The ClinicalTrials.gov registry entry for NCT07515872 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT07515872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07515872 about?
NCT07515872 is a clinical study titled "Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis". The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week period. The primary objective of this study is to evaluate the analgesic effect of ultrasound treatment in subjects sufferin...
What is the current status of trial NCT07515872?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2026-05-01. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07515872?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), Sustained Acoustic Device with 0% Diclofenac Patch (DEVICE), Intra articular injection (DRUG).
Who is sponsoring clinical trial NCT07515872?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.